Compare stocks

Evaluate stocks side by side, to find the best fit for your investment goals.
EssilorLuxottica is a French-Italian multinational corporation operating in the eyewear and eye care industry. It was formed through the merger of the French ophthalmic optics company Essilor and the Italian eyewear company Luxottica in 2018. The company designs, manufactures, and distributes ophthalmic lenses, optical equipment, and eyewear, including well-known brands such as Ray-Ban, Oakley, and Persol, as well as licensed brands like Chanel and Prada. Headquartered in Charenton-le-Pont, France, and Milan, Italy, EssilorLuxottica has a global presence with operations in over 150 countries. Its strategic positioning is underscored by its integrated business model that encompasses both retail and wholesale distribution, leveraging its extensive portfolio of proprietary and licensed brands.
View stock
VS
Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio and Jaypirca for cancer; Mounjaro, Zepbound, Foundayo, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.
View stock

Stock highlights

Stock comparison highlights
Stock name
EssilorLuxotticaEli Lilly
Last price
€145.75$1,170.07
Currency
EUR
USD
€66B$1T
26.9038.37
€5.35$29.79
0.550.50
€4.00$6.69
2.78%0.61%
Sector
HealthHealth
Employees
213,90950,000
Ticker
€EL$LLY
Primary listing
PARNYSE

Performance

CumulativeRolling yearsLump sum investment

Invest in €EL or $LLY on Lightyear

Save on broker fees and invest in 6000+ stocks and funds. When you invest, your capital is at risk.